Turkish ventures displayed their capabilities and newest merchandise at Europe’s greatest startup and know-how occasion, attracting hundreds of corporations and traders to Paris this week.
VivaTechnology, or VivaTech for brief, ran from Wednesday to Saturday. Sanofi attended the expo with three startups collaborating in its entrepreneurship program PharmUp, which helps startups aiming to create modern options within the healthcare subject.
The “Invest in Türkiye” sales space, arrange by the Presidential Investment Office, gathered as many as 16 startups beneath a single roof on the Paris Expo Porte de Versailles.
Highlighting the significance of the rising Türkiye-France relations, Ambassador to Paris Ali Onaner confused the chance to show the capabilities and alternatives his nation provides to international traders.
“We are pleased to host leading French investors and businesspeople, together with our Presidential Investment Office executives, to show French business people how attractive Türkiye is for foreign investors and to introduce our successful entrepreneurs participating in the VivaTech fair,” Onaner famous.
“We hope that this gathering will further increase the interest of French companies among the largest investors in Türkiye. We believe that the development of our political relations with France will contribute to the strengthening of our economic relations.”
$19 billion commerce quantity
Addressing a reception attended by French and Turkish business representatives, Burak Dağlıoğlu, the top of the Presidential Investment Office, underscored the financial cooperation between Türkiye and France and funding alternatives.
“In 2022, France became Türkiye’s seventh largest export and eighth largest import partner, with bilateral trade volume reaching $19 billion. Direct investment inflows from France to Türkiye have exceeded $8 billion since 2002, and approximately 1,700 French companies continue to operate in our country,” defined Dağlıoğlu.
“Under the leadership of our president, as we enter the second century of our republic, the ‘Türkiye Century,’ we continue our efforts to invite international investors, especially from France, to our country with all our energy.”
Health care startups
Three well being care startups accepted into Sanofi’s entrepreneurship program PharmUp left their mark at VivaTech and supplied them alternatives to fulfill potential traders and arrange networks with different entrepreneurs within the international market.
Among these, Hekimanne options an software that enables households to trace their kids’s well being information and a garment that measures temperature throughout a fever.
Labenko exhibited a robotic that eliminates ready in blood testing laboratories in state hospitals, whereas Meddenovo displayed molecular and simulation strategies for drug discovery research in Türkiye.
These well being care startups attracted consideration at Paris VivaTech, offering alternatives to fulfill potential traders and community with different entrepreneurs within the international market.
Meanwhile, Syntonym, a man-made intelligence-based options startup supported by Türk Telekom’s company enterprise capital firm, TT Ventures, was additionally among the many collaborating corporations on the Paris expo.
Revolutionizing drug design
Meddenovo, the Turkish initiative targeted on long-term drug design and modeling of biomolecular techniques, claims to be among the many distinguished startups on the earth.
Founded by Ilke Uğur Marion and Antoine Marion, Meddenovo – Drug Discovery has performed scientific analysis in drug design and biomolecular system modeling for over 10 years.
Antoine Marion stated the corporate brings collectively analysis teams, corporations and high-level computational chemistry and simulation strategies for brand spanking new drug discovery.
“Various and complex diseases and the global pandemic demonstrate the continuous need for innovative transformations in medicine. To effectively meet this need, higher technological inputs are required in drug discovery research,” Marion famous.
“At Meddenovo, we are proud to be one of the companies that provide advanced technology solutions in drug design with our software and experienced team of scientists.”
Original drug design in Türkiye
Marion additionally confused targets that the corporate appears to attain within the close to future.
“Our priority is to introduce our software that enables drug design with a ‘single click.’ We have been involved in numerous valuable studies regarding original drug development in Türkiye, and many of them were initiated by us. Continuing the journey of these studies towards the clinic is also one of the most important parts of our agenda,” he famous.
As of October this 12 months, Marion stated the corporate plans to open a department in France.
“The ecosystems in Türkiye and France are very different and complement each other in some aspects. We have innovative and high-tech projects that will bring together the advantages of both ecosystems. Each completed project is a candidate to meet the modeling needs in the market,” he added.
Marion emphasised that the bioAIM software program, on the core of Meddenovo, was initially developed to fulfill their very own wants, because the obtainable software program in the marketplace didn’t fulfill their necessities within the subject of drug growth.
“There is a balance between speed and accuracy in simulations. To increase speed and work with larger data, one must sacrifice accuracy. For now, there is no other way around it. A significant portion of our competitors is developing software to increase speed further. However, we do not compromise on accuracy and keep the speed low. As a result, we achieve highly accurate results,” he defined.
At the identical time, Marion stated the corporate didn’t need to lose its skill to work with large information. “This is where our focalYZe module, where we also benefited from the artificial intelligence, comes into play,” he famous.
“PharmUp emerged during a period when we were taking steps towards globalization. Globalization and growth are challenging journeys. It’s a path where you can easily get lost without guidance. PharmUp guided us on this path and accelerated our process significantly. It helped us remove obstacles along the way. Its contribution to clarifying our priorities was immense,” stated Marion.
Instantly measuring kids’s fever
Pediatrician Görkem Astarcıoğlu stated she launched Hekimanne after witnessing the helplessness skilled by households, stressing she had encountered related issues amongst about 200,000 mother and father on account of his experience.
“While parents strive to become more equipped caregivers as their children grow, they were struggling to archive their health data and measure and monitor body temperature during periods of feverish illnesses. Therefore, I decided to develop the BabyStar mobile health application and the TempStar wearable thermometer,” Astarcıoğlu defined.
She says becoming a member of PharmUp allowed her to see the massive image from an exterior perspective, fill within the gaps she couldn’t discover, and switch towards the worldwide market.
“It supported us in being able to attend a technology fair like VivaTech, which I’m sure will be a groundbreaking experience,” Astarcıoğlu stated.
Highlighting the significance of contributing to elevating wholesome people in mild of sustainable international targets worldwide, Astarcıoğlu continued: “We want to provide a solution that breathes new life into the health care system by enabling individuals to take responsibility for archiving their health data, thereby saving money and time spent on the health care system and supporting a less anxious experience during feverish illnesses.”
Error-free blood pattern assortment
Süleyman Sevinç stated the Labenko venture was influenced by the will to stop overcrowding after the then-chief doctor of Tepecik Education and Research Hospital, Gökhan Akbulut, noticed that sufferers needed to line up 3 times to supply blood samples.
The venture includes a robotic developed, which Sevinç says has been named Nesli, in reminiscence of his late mom, Neslihan.
“The confusion caused by carrying tubes by hand, chaos in units where multiple queues formed and unpredictable waiting times were causing stress for patients who had to wait for blood tests with an empty stomach,” he stated.
“Additionally, the timing of those who needed to provide blood samples at certain intervals, such as oral glucose tolerance tests, was not done accurately enough. We developed the system piece by piece with the support of TÜBİTAK/TEYDEB. The produced parts were used at TEAH and some other hospitals,” Sevinç famous.
TEYDEB stands for Technology and Innovation Support Programs Directorate of TÜBİTAK, particularly the Scientific and Technological Research Council of Türkiye.
The excessive satisfaction stage, Sevinç says, additional elevated their motivation.
“Finally, we produced and implemented the labeling robot with the support of TÜBİTAK/TEYDEB. There were no longer any queues in the blood collection unit. Before coming to the unit, patients could see the density of the unit through an application and adjust their timing accordingly,” he added.
“Unfortunately, my dear mother, Neslihan, couldn’t see the emergence of the robot, but she provided us with great support in our development efforts, so we wanted to thank her in this way.”
Sevinç says they developed the KANKA robotic, which makes use of synthetic intelligence to test blood samples for pre-analytical errors on the laboratory entrance, with the information that they had accrued within the Phlerobo venture.
He additionally acknowledged that their goal market is Europe, particularly the United Kingdom.
“PharmUp has been and continues to be an eye-opening experience for us. We understood the perspective of customers and investors regarding our products. Instead of long and potentially boring academic presentations, which we used to make frequently, we started presenting short and easily understandable presentations. We managed to obtain our patent. PharmUp taught us how to prioritize as we transitioned from the startup to the scaling phases,” Sevinç famous.
He acknowledged that they had performed market analysis within the United Kingdom, Germany, France and the Netherlands.
“We started working with a group in the United States and made some exports. Now, while striving to benefit our society primarily with the technologies we have developed, we also aim to provide much-needed foreign currency inflows to our country through exports.”
Source: www.dailysabah.com
